China NMPA Product Recall - Knee joint surgical tools

Johnson & Johnson (Shanghai) Medical Devices Co., Ltd., on behalf of manufacturer DePuy Orthopaedics, Inc., initiated a voluntary Class II recall of specific Knee Joint Surgical Instruments, as announced by the National Medical Products Administration (NMPA) on September 29, 2015. The recall was prompted by the discovery that the SP2 intramedullary rod, a critical component within these instruments, is prone to fracture under fatigue or excessive torque, particularly at a deep J-groove near its tip. This structural defect presents several significant clinical risks.

The primary issues include the potential for surgical delays and minor bone damage if a fracture is detected during knee replacement surgery. If the breakage remains undetected intraoperatively, it can lead to more severe complications such as bone remodeling, inflammation, adverse tissue reactions, and pain during magnetic resonance imaging (MRI), often necessitating subsequent revision surgery for patients. Two adverse events related to these fractures had been reported in China prior to the recall.

In response, Johnson & Johnson implemented required corrective actions, which involved immediately notifying all affected customers to discontinue using the implicated products and to contact Johnson Medical. Additionally, all identified affected products—including 73 consigned units and 58 units in stock within China (none had been sold)—were slated for local destruction. This global recall action, encompassing various identified batch numbers, underscores the company's commitment to product safety under the NMPA's regulatory oversight.